elements
-live
Search elements, keywords, and sectors
🔎
Elements
Subjects
Pricing
Log in
Sign up
Home
/
Subjects
/
Prostate-specific antigen
← Back to subjects
Current data, viewed at
Yearly
resolution.
Personal members see monthly resolution →
Keyword
keyword
Prostate-specific antigen
RIS
0.003
(Research Intensity Score)
Papers
409
Top papers
Outcomes of Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer
2020 · 1149 citations
PSMA-PET/CT Findings in Patients With High-Risk Biochemically Recurrent Prostate Cancer With No Metastatic Disease by Conventional Imaging
2025 · 62 citations
Dual-resonance optical fiber lossy mode resonance immunoprobe for serum PSA detection
2024 · 48 citations
177 Lu-Prostate-Specific Membrane Antigen Neoadjuvant to Stereotactic Ablative Radiotherapy for Oligorecurrent Prostate Cancer (LUNAR): An Open-Label, Randomized, Controlled, Phase II Study
2025 · 24 citations
Gallium-68 Prostate-specific Membrane Antigen Positron Emission Tomography in Advanced Prostate Cancer—Updated Diagnostic Utility, Sensitivity, Specificity, and Distribution of Prostate-specific Membrane Antigen-avid Lesions: A Systematic Review and Meta-analysis
2019 · 962 citations
Exosomal Liquid Biopsy in Prostate Cancer: A Systematic Review of Biomarkers for Diagnosis, Prognosis, and Treatment Response
2025 · 35 citations
Prostate-Specific Membrane Antigen PET-Guided Intensification of Salvage Radiotherapy After Radical Prostatectomy
2025 · 21 citations
Activity and Adverse Events of Actinium-225-PSMA-617 in Advanced Metastatic Castration-resistant Prostate Cancer After Failure of Lutetium-177-PSMA
2020 · 275 citations
Fluorine-18 Prostate-Specific Membrane Antigen–1007 PET/CT vs Multiparametric MRI for Locoregional Staging of Prostate Cancer
2024 · 40 citations
Newest papers
Assessment of risk factors and biomarkers of prostate disease
2026
PSMA PET/CT–Derived Indicators and Outcomes After [ 177 Lu]Lu-PSMA-617: A Multicenter Retrospective Analysis from the U.S. Expanded-Access Program
2026 · 2 citations
Phase 2 Prospective Trial of Retreatment with [ 177 Lu]Lu-PSMA-617 Molecular Radiotherapy for Metastatic Castration-Resistant Prostate Cancer—RE-LuPSMA
2026 · 2 citations
MRI-derived T stage predicts nodal positivity on PSMA PET/CT in high-risk primary prostate cancer
2026
Diagnosis and treatment of metastatic prostate cancer in low- and middle-income countries: challenges, adaptive strategies, and lessons from sub-Saharan Africa
2026
Prostate-specific membrane antigen theranostics in current clinical use
2026
A lateral flow immunoassay strip employing upconversion luminescence for quantitative detection of prostate-specific antigen
2026 · 2 citations
Predictors of Treatment Failure and Second-Line Therapy Outcomes After Rezūm Therapy for Benign Prostatic Hyperplasia
2026
Sequential therapy with radium-223 chloride and 177Lu-PSMA in patients with metastatic castration-resistant prostate cancer
2026
Browse all papers →
Prostate-specific antigen's history
Research intensity over time
Yearly
Personal members see monthly resolution →
Data temporarily unavailable — please try again shortly.
Close ✕
Prostate-specific antigen's papers
Ordered by current research-activity contribution.
Loading…
Close ✕
Read full text ↗
Share
Share on X
Share on Facebook
Share on LinkedIn
Copy link